The Enterprise Value as of December 2025 (TTM) for Mendus AB (publ) (IMMU.ST) is 215.77M

According to Mendus AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 215.77M. This represents a change of -29.54% compared to the average of 306.22M of the last 4 quarters.

Mendus AB (publ) (IMMU.ST) Historical Enterprise Value (quarterly & annually)

How has IMMU.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Mendus AB (publ) over the last ten years is 9.05B. The current 215.77M Enterprise Value has changed 138.34% with respect to the historical average. Over the past ten years (40 quarters), IMMU.ST's Enterprise Value was at its highest in in the December 2020 quarter at 24.48B. The Enterprise Value was at its lowest in in the March 2025 quarter at 240.38M.

Mendus AB (publ) (IMMU.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Mendus AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Mendus AB (publ) (IMMU.ST) Average Enterprise Value

How has IMMU.ST Enterprise Value performed in the past?

The current Enterprise Value of Mendus AB (publ) (IMMU.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Mendus AB (publ) (IMMU.ST) Enterprise Value vs. Peers

How is IMMU.ST’s Enterprise Value compared to its peers?

Mendus AB (publ)’s Enterprise Value is less than Ascelia Pharma AB (publ) (278.52M), greater than Intervacc AB (publ) (133.77M), less than Magle Chemoswed Holding AB (publ) (667.02M), greater than Xintela AB (publ) (175.27M), greater than Moberg Pharma AB (publ) (189.53M), less than Elicera Therapeutics AB (publ) (250.47M), greater than Karolinska Development AB (publ) (57.49M), less than Lipum AB (publ) (341.46M), less than Corline Biomedical AB (410.53M), greater than Isofol Medical AB (publ) (140.80M),

Build a custom stock screener for Mendus AB (publ) (IMMU.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mendus AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mendus AB (publ) (IMMU.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mendus AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.